In addition, patients with pelvis chondrosarcoma in the negative SIRT1 expression group showed a favorable survival outcome (P = 0.043), with mean survival times of 53.8 months, respectively compared with those of the positive expression group survival times of 37.7 months. The gene discussed is SIRT1; the disease is chondrosarcoma.